Antimalarial drug mefloquine inhibits nuclear factor kappa B signaling and induces apoptosis in colorectal cancer cells

Abstract

Nuclear factor kappa B (NF‐κB) signaling pathway is activated in many colorectal cancer (CRC) cells and in the tumor microenvironment, which plays a critical role in cancer initiation, development, and response to therapies. In the present study, we found that the widely used antimalarial drug mefloquine was a NF‐κB inhibitor that blocked the activation of IκBα kinase, leading to reduction of IκBα degradation, decrease of p65 phosphorylation, and suppressed expression of NF‐κB target genes in CRC cells. We also found that mefloquine induced growth arrest and apoptosis of CRC cells harboring phosphorylated p65 in culture and in mice. Furthermore, expression of constitutive active IKKβ kinase significantly attenuated the cytotoxic effect of the compound. These results showed that mefloquine could exert antitumor action through inhibiting the NF‐κB signaling pathway, and indicated that the antimalarial drug might be repurposed for anti‐CRC therapy in the clinic as a single agent or in combination with other anticancer drugs.

Overexpression of CMTM7 inhibits cell growth and migration in liver cancer

“…Each well was added 1/10 μL volume of CCK‐8 (Bimake, Houston, Texas). After incubating for 2 hours, the absorbance of each well was measured at 450 nm using SpectraMax i3x as previously described …”

Ubiquitin‐specific protease 44 inhibits cell growth by suppressing AKT signaling in non‐small cell lung cancer

“…A549 and H1975 cells were stably infected with PLVX‐NC or PLVX‐USP44 lentivirus, and then cells were incubated in 96‐well plates for 0, 1, 3, or 5 days, followed by Cell Counting Kit‐8 (CCK‐8) staining according to the manufacturer's instructions (Biotool, Houston, TX) as described previously …”

Nitroxoline induces cell apoptosis by inducing MDM2 degradation in small‐cell lung cancer

“…SCLC cells were plated at a start density of 4000 cells per well into 96‐well plates overnight. Then, cells were incubated with different concentrations of NXQ for indicated time, and the viable cells were evaluated by Cell Counting Kit‐8 (CCK‐8) staining according to the manufacturer's instructions (Biotool, Houston, Texas) as described previously …”